Ireland has officially joined ECRIN as a Member Country. This brings ECRIN’s number of Member countries to nine (Czech Republic, France, Germany, Hungary, Ireland, Italy, Norway, Portugal and Spain), with two Observer countries (Switzerland and Slovakia).
"PCN Santé" is organising a webinar on December 10th at 10am (CET) on the European Joint Programme on Rare Diseases (EJP-RD), which was recently funded by the European Commission.
Increasing demand and the use of high-quality samples, data and services place biobanks at the centre of basic and applied research.
ECRIN is hosting a staff exchange as part of the RItrain project from 22 to 23 November 2018 in Paris.
ECRIN participated in the “2018 KoNECT-MFDS International Conference” in Seoul, Korea, from October 31st to November 2nd.
Rome, Italy, 31 October, 2018.
The International Consortium for Personalised Medicine, ICPerMed, publishes today the pre-announcement of their second “BEST PRACTICE IN PERSONALISED MEDICINE" RECOGNITION 2019.
ECRIN's Alicja Szofer-Araya is featured in a short video on the Executive Master in Management of Research Infrastructures (EMMRI).
Open Call for Vaccine Development Services
BBMRI-ERIC, EATRIS and ECRIN have released a joint statement on Horizon Europe.
In their joint paper, they identify four critical success factors for optimal outcomes in the next funding period with regard to the upcoming Horizon Europe framework programme:
IDIBAPS has recently launched the 2nd international peer-reviewed BITRECS call
Are you involved in developing Equality & Diversity practices for or within a Research Infrastructure? Registrations are open for the RItrain Workshop on Equality, Diversity & Inclusion hosted by EMBL-European Bioinformatics Institute, 29-30 October 2018.
Innovative Global Data-Sharing Platform Vivli Launches with 2,500 Clinical Studies from 15 organizations with data from more than 98 countries across numerous disease areas, including diabetes, Alzheimer’s and malaria, and representing the contributions of more than 1.3 million trial participants
